// App-Quantinova.ai

QOLP-02 : HEALTH-RELATED QUALITY OF LIFE (HRQOL) AMONG PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND PLEXIFORM NEUROFIBROMA (PN) IN THE UNITED STATES: PERSPECTIVES OF THE PATIENTS AND CAREGIVERS

Researchers

Presenter

  • Xiaoqin Yang

Principal Investigators

  • Hyun Kyoo Yoo

  • Suvina Amin

  • Wendy Cheng

  • Heather Sipsma

  • Sanjana Sundaresan

  • Lujia Zhang

  • Mei Sheng Duh

Medical Centers

  • AstraZeneca, Gaithersburg, MD, USA

  • AstraZeneca, Cambridge, UK

  • Analysis Group, Boston, MA, USA

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Neurofibromatosis type 1

Biomarkers

  • Neurofibromatosis type 1

Drug/Treatment

  • selumetinib

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved